In the fast-paced world of pharmaceuticals, keeping your Key Opinion Leader (KOL) lists current and relevant is like trying to hit a moving target that's constantly changing direction. As someone who’s spent years immersed in this industry, I can tell you that CRM-based KOL lists are notorious for going stale, often lagging reality by 6-18 months due to their reliance on rep memory and outdated data.
Why does this happen? Well, it's not because reps aren't doing their jobs. It’s simply a matter of scale and the speed at which things move in our industry. New studies are published every day, new trials start, and KOLs change roles or leave institutions. This dynamic landscape means that the data stored within your CRM system quickly becomes outdated.
The problem is exacerbated by how these lists are typically maintained. Most rely heavily on manual inputs from sales reps who may not have the bandwidth to keep up with every publication, trial update, or career change of their KOLs. Even if they do try, the information often gets siloed within individual CRM records rather than being aggregated into a comprehensive view.
But there’s hope! The solution lies in systematically scoring your KOLs based on specific criteria that reflect their current relevance and influence. This means moving away from rep-driven updates and towards data-driven insights. Here's what you need to focus on:
First, track publication velocity. A KOL who is consistently publishing high-impact studies is likely influencing the field more than one who hasn’t published in years. By monitoring how often and where they publish, you can quickly identify those whose expertise is most relevant today.
Secondly, evaluate trial Principal Investigator (PI) status. Being a PI on an important clinical trial can be a significant indicator of influence. Make sure your KOL list reflects who's leading the charge in current research efforts.
Finally, consider recency signals. These could include recent speaking engagements at major conferences, new appointments within institutions, or even changes in their social media presence. The more recently these events occurred, the fresher and more relevant the information is.
To implement this effectively, you need to integrate a scoring system that automatically updates based on these factors. This can be done through advanced analytics tools that continuously monitor databases of publications, trials, and professional profiles, feeding back into your CRM with actionable insights.
The payoff for taking this approach is significant. Not only will it ensure your KOL lists are always up-to-date, but they’ll also provide a clear picture of who the most influential voices in your field currently are—information that can drive everything from clinical trial recruitment to market strategy development.
So my recommendation is straightforward: invest in a robust system for scoring and updating your KOLs based on these criteria. This not only ensures you're engaging with the right people but also positions you to leverage their expertise more effectively, driving better outcomes for both your company and patients alike.